Protego Bio

Biotechnology Research • San Diego, California, United States • 11-20 Employees

Company overview

Headquarters	10945 Vista Sorrento Pkwy, Suite 150, San Diego, California 92130, US
Phone number	+18583559290
Website	protegobio.com
NAICS	541714
SIC	283
Employees	11-20
Socials

Key Contacts at Protego Bio

Brent Warner

Chief Executive Officer, Board Member

Bo Qin

Associate Director

Virginia Grant

Director Program Management

Protego Bio Email Formats

Protego Bio uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@protegobiopharma.com), used 56.2% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@protegobiopharma.com	68.7%
{first name}{last name}	johndoe@protegobio.com	31.2%

About Protego Bio

Protego Bio is a clinical-stage company focused on the discovery and development of first-in-class small-molecule therapeutics that aim to reprogram protein folding for the treatment of various diseases. We are exploring monogenetic protein misfolding diseases that cause myopathy, cardiomyopathy, stroke, renal disease, retinal diseases, channelopathies, and various degenerative diseases. Our approach builds on the proven pharmacological chaperone strategy exemplified by tafamidis, which was discovered and developed by our cofounders, Dr. Jeffery W. Kelly and Dr. Richard Labaudinière, for the treatment of transthyretin amyloidosis.

Protego Bio revenue & valuation

Annual revenue	$4,200,000
Revenue per employee	$210,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$13,500,000
Total funding	$51,000,000